News
Zacks.com on MSN9h
Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?Emrelis wins FDA approval, marking ABBV's first lung cancer drug and strengthening its oncology reach into solid tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback